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Tracking a 
ON THE TRAIL OF 
A FATAL LIVER DISEASE 
n February 23, 1983, a comatose 
three-day-old Standardbred foal was 
admitted to the George D. Widener 
Hospital for Large Animals at New 
Bolton Center. The filly, healthy and 
normal for the first forty hours of its 
life, had suddenly become uncoordi­
nated and then comatose. Tests indi­
cated that its liver was not adequately 
functioning. 
It was the first of eight foals with liver failure 
seen at New Bolton Center. Practitioners in other 
parts of the country also reported similar cases. 
During the spring of 1983 sixty foals in eleven 
states succumbed to liver failure caused by an 
unidentified disease. 
Researchers at New Bolton Center and at 
other institutions launched a concentrated effort 
to determine the cause of this apparently new 
liver disease. A team of clinicians and research 
investigators at the New Bolton Center conducted 
extensive laboratory and pathologic studies as 
well as epidemiologic surveys. It was found that 
foals with the disease had been healthy and nor­
mal at birth and that the first signs of liver failure 
had appeared between the age of two and five 
days when the foals became disoriented, weak, 
and jaundiced. Some foals were hypoglycemic, 
others were hypothermic, and some had elevated 
heart rates when admitted to the hospital. 
Pathologic studies showed the livers of these 
animals to be shrunken and damaged. It was also 
found that the thymus glands were smaller than 
in healthy animals, and that microscopic lesions 
had occurred in the brains. The tissue and blood 
samples were examined for evidence of equine 
herpes virus I and viral hepatitis B, but no evi­
dence of either disease was found. During further 
studies the researchers also ruled out foal sep­
ticemia, neonatal isoerythrolysis and Tyzzer's dis­
ease as the possible causes of the liver failure. 
The foals seen at New Bolton 
Center as well as the foals seen 
elsewhere had received a live 
culture product reported to 
enhance intestinaljlora shortly 
after birth. 
The pathologic findings of the damaged liv­
ers suggested liver failure due to a toxin. It was 
thought that the foals had been exposed to such 
toxin in utero. However, no evidence of such 
toxins was found in the mares or the foals. The 
feed of a number of mares was analyzed and no 
toxins were found. The pregnant mares had not 
received unusual drugs or live vaccines and the 
pregnancies had been normal, without 
complications. 
The researchers also looked at the incidence 
pattern of the disease. They found that it 
occurred suddenly in a few foals. Prior to the 
appearance of the disease, and after it, healthy 
foals had been born and raised on these same 
farms. Checking back it was found that in 1981 
there had been six cases of liver failure in very 
young foals in New Jersey and Maryland. 
The team began to look at the possibility that 
the liver damage had occurred after birth. 
Changes similar to those found in the liver tissue 
of the foals had been documented in a horse 
which died after receiving aflatoxins (toxins pro­
duced by fungi). 
The researchers examined the substances the 
foals had received shortly after birth as it seemed 
most likely, based upon epidemiologic evidence, 
that a hepatoxin administered to the foals shortly 
after birth was responsible for this new and un­
usual syndrome. The foals seen at New Bolton 
Center as well as the foals seen elsewhere had re­
ceived a live culture product reported to enhance 
intestinal flora shortly after birth. The widely 
used product was given on the first and third day 
of life and this may explain why some cases of 
liver failure occurred at two and three days of age 
and others at the age of five days. 
The product contains Aspergillus oriza which 
may produce a potential hepatoxin. The product 
also contains iron fumalzate, another known 
hepatoxin. It was found that the foals which died 
from the disease in 1981 also received an identical 
product. The product has been given to hundreds 
of foals without ill-effect. This could suggest that 
individual vials of the product are to blame. The 
sporadic incidence could also be related to the age 
of the foal at the time of product administration. 
Universities are continuing the search for the 
exact cause of the liver failure in very young 
foals. Epidemiologic surveys and toxicologic and 
immunologic tests are being conducted to deter­
mine the precise etiology and pathophysiology of 
this fatal disease. 
The studies at New Bolton Center are being 
conducted by Dr. Thomas J .  Divers, Dr. Helen 
Acland, Dr. Lawrence Glickman, Dr. Diane 
Gunson, Dr. Jonathan Palmer, Dr. Angeline 
Warner, Dr. Robert Whitlock, and Dr. Dennis 
Hill. The study is made possible by a grant to the 
Equine Research Fund at New Bolton Center, 
University of Pennsylvania. 
During the spring of 1983 sixty 
foals in eleven states succumbed 
to liver faUure caused by an 
unidentified disease. 
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